维普中文期刊产品整合服务
64篇 您的检索式:作者名="FRANK JP"
    题名 作者 年代 出处 被引量
1Trends in treatment and overall survival among patients with proximal esophageal cancer显示文摘BACKGROUND The management of proximal esophageal cancer differs from that of tumors located in the mid and lower part of the esophagus due to the close vicinity of vital structures.Non-surgical treatment options like radiotherapy and definitive chemoradiation(CRT)have been implemented.The trends in(non-)surgical treatment and its impact on overall survival(OS)in patients with proximal esophageal cancer are unclear,related to its rare disease status.To optimize treatment strategies and counseling of patients with proximal esophageal cancer,it is therefore essential to gain more insight through real-life studies.AIM To establish trends in treatment and OS in patients with proximal esophageal cancer.METHODS In this population-based study,patients with proximal esophageal cancer diagnosed between 1989 and 2014 were identified in the Netherlands Cancer Registry.The proximal esophagus consists of the cervical esophagus and the upper thoracic section,extending to 24 cm from the incisors.Trends in radiotherapy,chemotherapy,and surgery,and OS were assessed.Analyses were stratified by presence of distant metastasis.Multivariable Cox proportional hazards regression analyses was performed to assess the effect of period of diagnosis on OS,adjusted for patient,tumor,and treatment characteristics.RESULTS In total,2783 patients were included.Over the study period,the use of radiotherapy,resection,and CRT in non-metastatic disease changed from 53%,23%,and 1%in 1989-1994 to 21%,9%,and 49%in 2010-2014,respectively.In metastatic disease,the use of chemotherapy and radiotherapy increased over time.Median OS of the total population increased from 7.3 mo[95%confidence interval(CI):6.4-8.1]in 1989-1994 to 9.5 mo(95%CI:8.1-10.8)in 2010-2014(logrank P<0.001).In non-metastatic disease,5-year OS rates improved from 5%(95%CI:3%-7%)in 1989-1994 to 13%(95%CI:9%-17%)in 2010-2014(logrank P<0.001).Multivariable regression analysis demonstrated a significant treatment effect over time on survival.In metastatic disease,median OS was 3.8 mo(95%CI:2.5-5.1)in 1989-1994,and 5.1 mo(95%CI:4.3-5.9)in 2010-2014(logrank P=0.26).CONCLUSION OS significantly improved in non-metastatic proximal esophageal cancer,likely to be associated with an increased use of CRT.Patterns in metastatic disease did not change significantly over time.Judith de Vos-Geelen Sandra ME Geurts Liselot BJ Valkenburg-van Iersel Evelien JM de Jong Vivianne CG Tjan-Heijnen Margreet van Putten Valery EPP Lemmens Heike I Grabsch Nadia Haj Mohammad Frank JP Hoebers Chantal V Hoge Paul M Jeene Hanneke WM van Laarhoven Tom Rozema Marije Slingerland Grard AP Nieuwenhuijzen 2019World Journal of Gastroenterology2019,25,47:2
2Correction or deafness in shaker-2 mice by anunconventional myosin in a BAC transgene显示文摘9,Frank JP Robert AF Yehoash R 1998Science1998,280,:1
3Epidemic profile of Shiga-toxin-producing Escherichia coli O101:H4 outbreak in Germany 显示文摘Frank C Werber D Cramer JP 2011N Engl J Med2011,365,:1
4Integrated pest management of pest mole crickets with emphasis on the southeastern USA 显示文摘Frank JH Parkman JP 1999Integrated Pest Management Reviews1999,4,:1
5Failures for disorders of syndromes; anterior cervical fixation deovaic by fixation of morscher screw, a biomechanic study显示文摘 Frank JR Morges PV 1994J Spine Disorder1994,7,2:1
6Cone - beam computed tomography for on -line image guidance of lung stereotactic radiotherapy: Loealisation, verification, and in- trafraction tumor position 显示文摘Purdie TG Bisonnette JP Franks K 2007Int J Radiat Oncol Biol Phys2007,68,7:1
7Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany 显示文摘Frank C Werber D Cramer JP 2011N Engl J Med2011,365,19:1
8Epidemic profile of Shigatoxin-producing Escherichia coli O104:H4 outbreak in Germany显示文摘Frank C Werber D Gramer JP 2011N Engl J Med2011,365,19:1
9Bad split during bilateral sagittal split osteotomy of the mandible with separators: a retrospec- tive study of 427 patients 显示文摘Mensink G Verweij JP Frank MD 2013Br J Oral Maxillofac Surg2013,51,6:1
10Epidemic profile of Shiga-toxin-producing Escherichia coli O104:H4 outbreak in Germany显示文摘Frank C Werber D Cramer JP 2011N Engl J Med2011,365,19:1
11Type III protein secretion is associated with death in lower respiratory and systemic Pseudomonas aeruginosa infections 显示文摘Roy-Burman A Savel RH Racine S Swanson BL Revadi- gar NS Fujimoto J Sawa T Frank DW Wiener-Kronish JP 2001J Infect Dis2001,183,12:1
12TRPM2:a Calcium Influx Pathway Regulated by Oxidative Stress and the Novel Second Messenger ADP-ribose显示文摘FRANK JP KUHN IH ANDREAS L 2005Pflugers Arch -Eur J Physiol(S0031-6768)2005,451,:1
13Active and passive immuni- zation with the Pseudomonas V antigen protects against type III intoxication and lung injury 显示文摘Sawa T Yahr TL Ohara M Kurahashi K Gropper MA Wiener-Kronish JP Frank DW 1999Nat Med1999,5,4:1
14Costs of needle stick inju- ries and subsequent hepatitis and HIV infection 显示文摘Leigh JP Gillen M Franks P 2007Curt Meal Res Opin2007,23,9:1
15Multiresidue Analysis of β2-Agonists in Human and Calf Urine Using Multimodal Solid-phase Extraction and High-Performance Liquid Chromatography with Electrochemical Detection显示文摘Koole A Bosman J Franke JP 1999J Chromatogr B1999,726,1:1
16Anode biofilm transcriptomics reveals outer surface components essential for high density current production in Geobacter sulfurreducens fuel cells 显示文摘Nevin KP Kim BC Glaven RH Johnson JP Woodard TL Meth6 BA DiDonato Jr RJ Covalla SF Franks AE Liu A 2009PLoS One2009,4,5:1
17Epidemic profile of Shiga-toxin-producing Eschierichia coli O104:H4 outbreak in Germany显示文摘Frank C Werber D Cramer JP 2011N Engl J Med2011,365,19:1
18Sumoylation of the nucleocapsid protein of severe acute respiratory syndrome coronavirus显示文摘Li Frank Qisheng Xiao Han Tam JP 2005FEBS Lett2005,579,:1
19Epidemic profile of Shiga- toxin-producing Escherichia coli O104 :H4 outbreak in Germany显示文摘Frank C Werber D Cramer JP 2011N Engl J Med2011,365,19:1
20Amyloid beta protein and tau incerebrospinal fluid and plasma as biomarkers for dementia: a review of recent literature 显示文摘Frank fort SV Tulner LR van Campen JP 2008Curr Clin Pharmacol2008,3,2:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费